Nanolek is a Russian fast-growing pharmaceutical company which aims to become one of the market leaders in the production of innovative biotechnological products and modern vaccines, stimulating the creation of the national bioeconomy and amplifying the country’s biosafety.
Nanolek’s product portfolio is formed in compliance with the priority therapeutic areas: cardiological and oncological products, innovative vaccines, including the cell-based influenza vaccine and the first Russian inactivated polio vaccine. In the meantime the company is also developing a number of biotech products, including new to the Russian market modern vaccines.
Company Details
- Employees
- 84
- Founded
- -
- Address
- Baker Plaza Business Center, Offi‡ce 45,, Level 4,building 1,68\70,butyrskiy Val,russian Federation
- Phone
- +7 (495) 648 26 87
- in****@****olek.ru
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- nanolek.ru
- HQ
- Moscow
Nanolek Questions
Nanolek's helpline number is +7 (495) 648 26 87
Nanolek's website is nanolek.ru
Nanolek's LinkedIn profile is https://ru.linkedin.com/company/nanolek
Nanolek has
84 employees.
View email and phone details for 84
employees at Nanolek.
Nanolek's industry is
Pharmaceutical Manufacturing
Nanolek's top competitors are
Geropharm,
R-Pharm,
Valenta Pharmaceuticals,
Petrovax Pharm,
Biocad,
Rus Biopharm,
Akrikhin,
Solopharm,
Generium,
Pharmasyntez Group Of Companies.
Nanolek's support email address is info@nanolek.ru
Nanolek's categories are Pharmaceutical Manufacturing
Nanolek's founding year is 2011
